Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
The global Anti-inflammatory Therapy market is projected to reach US$ 168750 million in 2029, increasing from US$ 110540 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-inflammatory Therapy market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anti-inflammatory Therapy market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Segment by Type
Corticosteroids
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs
Others
Segment by Application
Respiratory Diseases
Arthritis
Gastroenterology
Dermatology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Anti-inflammatory Therapy report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Anti-inflammatory Therapy 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Corticosteroids
1.2.3 Anti-inflammatory Biologics
1.2.4 Non-Steroidal Anti-inflammatory Drugs
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Anti-inflammatory Therapy 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Respiratory Diseases
1.3.3 Arthritis
1.3.4 Gastroenterology
1.3.5 Dermatology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapy 麻豆原创 Perspective (2018-2029)
2.2 Anti-inflammatory Therapy Growth Trends by Region
2.2.1 Global Anti-inflammatory Therapy 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anti-inflammatory Therapy Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Anti-inflammatory Therapy Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Anti-inflammatory Therapy 麻豆原创 Dynamics
2.3.1 Anti-inflammatory Therapy Industry Trends
2.3.2 Anti-inflammatory Therapy 麻豆原创 Drivers
2.3.3 Anti-inflammatory Therapy 麻豆原创 Challenges
2.3.4 Anti-inflammatory Therapy 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapy Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapy Players by Revenue (2018-2023)
3.1.2 Global Anti-inflammatory Therapy Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Anti-inflammatory Therapy 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-inflammatory Therapy Revenue
3.4 Global Anti-inflammatory Therapy 麻豆原创 Concentration Ratio
3.4.1 Global Anti-inflammatory Therapy 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapy Revenue in 2022
3.5 Anti-inflammatory Therapy Key Players Head office and Area Served
3.6 Key Players Anti-inflammatory Therapy Product Solution and Service
3.7 Date of Enter into Anti-inflammatory Therapy 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapy Breakdown Data by Type
4.1 Global Anti-inflammatory Therapy Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Anti-inflammatory Therapy Forecasted 麻豆原创 Size by Type (2024-2029)
5 Anti-inflammatory Therapy Breakdown Data by Application
5.1 Global Anti-inflammatory Therapy Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Anti-inflammatory Therapy Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Anti-inflammatory Therapy 麻豆原创 Size (2018-2029)
6.2 North America Anti-inflammatory Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anti-inflammatory Therapy 麻豆原创 Size by Country (2018-2023)
6.4 North America Anti-inflammatory Therapy 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapy 麻豆原创 Size (2018-2029)
7.2 Europe Anti-inflammatory Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anti-inflammatory Therapy 麻豆原创 Size by Country (2018-2023)
7.4 Europe Anti-inflammatory Therapy 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapy 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Anti-inflammatory Therapy 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anti-inflammatory Therapy 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Anti-inflammatory Therapy 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Therapy 麻豆原创 Size (2018-2029)
9.2 Latin America Anti-inflammatory Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anti-inflammatory Therapy 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Anti-inflammatory Therapy 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapy 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Anti-inflammatory Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anti-inflammatory Therapy 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Anti-inflammatory Therapy 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapy Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapy Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Detail
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapy Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Detail
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Detail
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapy Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapy Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapy Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapy Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapy Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Detail
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Detail
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapy Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapy Business (2018-2023)
11.12.5 TEVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
听
听
*If Applicable.